Literature DB >> 19568878

Association of serum NO( x ) level with clustering of metabolic syndrome components in middle-aged and elderly general populations in Japan.

Jun Ueyama1, Takaaki Kondo, Ryota Imai, Akiko Kimata, Kanami Yamamoto, Koji Suzuki, Takashi Inoue, Yoshinori Ito, Ken-Ichi Miyamoto, Takaaki Hasegawa, Nobuyuki Hamajima.   

Abstract

OBJECTIVES: The aim of this study was to determine whether the serum nitrite plus nitrate (NO( x )) level correlates with biomarkers that are known components of the metabolic syndrome (MetS).
METHODS: Serum NO( x ) levels were measured using a commercial kit in 608 Japanese men and women between the ages of 39 and 85 years. Multivariate adjustments for age, smoking status, alcohol consumption and exercise were made in the analysis of covariance (ANCOVA). The components of the metabolic syndrome were defined based on the following criteria: body mass index (BMI) >/=25.0 kg/m(2), glycated hemoglobin (HbA1c) >/=5.6%, systolic blood pressure >/=130 mmHg or diastolic blood pressure >/=85 mmHg, high-density lipoprotein-cholesterol (HDL-C) </=1.03 mmol/l for men and </=1.29 mmol/l for women and triglyceride >/=1.69 mmol/l.
RESULTS: The logarithmically transformed age-adjusted serum NO( x ) (lnNO( x )) value was significantly higher in the low HDL-C group (1.76 +/- 0.05 mumol/l; p < 0.05) than MetS component groups (1.65 +/- 0.01 mumol/l) in men, but no difference was found in women. The means of serum lnNO( x ) after multivariate adjustment were 1.64, 1.65, 1.64, 1.66, and 1.81 mumol/l for 0, 1, 2, 3, and 4-5 MetS components for all subjects, respectively. The results of ANCOVA confirmed that the serum lnNO( x ) level was significantly correlated with the clustering of MetS components in both men and women (p < 0.0001 for trend).
CONCLUSION: Our results suggest that an increase in the clustering of MetS components was associated with the increase in serum NO levels in our general population.

Entities:  

Year:  2007        PMID: 19568878      PMCID: PMC2698239          DOI: 10.1007/s12199-007-0001-1

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  25 in total

1.  Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications.

Authors:  K Maejima; S Nakano; M Himeno; S Tsuda; H Makiishi; T Ito; A Nakagawa; T Kigoshi; T Ishibashi; M Nishio; K Uchida
Journal:  J Diabetes Complications       Date:  2001 May-Jun       Impact factor: 2.852

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

3.  Prevalence of metabolic syndrome in Okayama prefecture, Japan.

Authors:  Nobuyuki Miyatake; Yuriko Kawasaki; Hidetaka Nishikawa; Sumiko Takenami; Takeyuki Numata
Journal:  Intern Med       Date:  2006-02-15       Impact factor: 1.271

4.  Metabolic syndrome and urinary cGMP excretion in general population.

Authors:  Renzhe Cui; Hiroyasu Iso; Jingbo Pi; Yoshito Kumagai; Kazumasa Yamagishi; Takeshi Tanigawa; Takashi Shimamoto
Journal:  Atherosclerosis       Date:  2006-03-24       Impact factor: 5.162

Review 5.  Development of genetically engineered mice lacking all three nitric oxide synthases.

Authors:  Masato Tsutsui; Hiroaki Shimokawa; Tsuyoshi Morishita; Yasuhide Nakashima; Nobuyuki Yanagihara
Journal:  J Pharmacol Sci       Date:  2006-10-07       Impact factor: 3.337

Review 6.  Endothelial and antithrombotic actions of HDL.

Authors:  Chieko Mineo; Hiroshi Deguchi; John H Griffin; Philip W Shaul
Journal:  Circ Res       Date:  2006-06-09       Impact factor: 17.367

7.  Endogenous nitric oxide in patients with chronic heart failure (CHF): relation to functional impairment and nitrate-containing therapies.

Authors:  E Clini; M Volterrani; M Pagani; L Bianchi; R Porta; L S Gile'; A Giordano; N Ambrosino
Journal:  Int J Cardiol       Date:  2000-04-28       Impact factor: 4.164

8.  Serum and urinary nitrites and nitrates and Doppler sonography in children with diabetes.

Authors:  Alessandra Savino; Piernicola Pelliccia; Cosima Schiavone; Alessandra Primavera; Stefano Tumini; Angelika Mohn; Francesco Chiarelli
Journal:  Diabetes Care       Date:  2006-12       Impact factor: 19.112

9.  iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion.

Authors:  D G Binion; S Fu; K S Ramanujam; Y C Chai; R A Dweik; J A Drazba; J G Wade; N P Ziats; S C Erzurum; K T Wilson
Journal:  Am J Physiol       Date:  1998-09

10.  Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice.

Authors:  Stéphane Cook; Olivier Hugli; Marc Egli; Peter Vollenweider; Rémy Burcelin; Pascal Nicod; Bernard Thorens; Urs Scherrer
Journal:  Swiss Med Wkly       Date:  2003-06-28       Impact factor: 2.193

View more
  4 in total

Review 1.  Is nitric oxide a hormone?

Authors:  Asghar Ghasemi; Saleh Zahediasl
Journal:  Iran Biomed J       Date:  2011

2.  Nitric oxide and clustering of metabolic syndrome components in pediatrics.

Authors:  Asghar Ghasemi; Saleh Zahediasl; Fereidoun Azizi
Journal:  Eur J Epidemiol       Date:  2009-08-22       Impact factor: 8.082

3.  Oxidative status imbalance in patients with metabolic syndrome: role of the myeloperoxidase/hydrogen peroxide axis.

Authors:  Lucas José Sá da Fonseca; Valéria Nunes-Souza; Glaucevane da Silva Guedes; Glauber Schettino-Silva; Marco Antônio Mota-Gomes; Luíza Antas Rabelo
Journal:  Oxid Med Cell Longev       Date:  2014-10-15       Impact factor: 6.543

4.  Association of plasma nitrite levels with obesity and metabolic syndrome in the Old Order Amish.

Authors:  F Akram; D Fuchs; M Daue; G Nijjar; A Ryan; M E Benros; O Okusaga; E Baca-Garcia; L A Brenner; C A Lowry; K A Ryan; M Pavlovich; B D Mitchell; S Snitker; T T Postolache
Journal:  Obes Sci Pract       Date:  2018-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.